scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YEXCR.2020.112382 |
P698 | PubMed publication ID | 33253709 |
P50 | author | Guoying Zhou | Q89436963 |
P2093 | author name string | Jingmei Hou | |
Yunting Lin | |||
Ruitao Lu | |||
Wenmin Fu | |||
P2860 | cites work | Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments | Q26766132 |
The IFN gamma receptor: a paradigm for cytokine receptor signaling | Q28237623 | ||
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy | Q33463332 | ||
Clonogenic assay of cells in vitro. | Q34615431 | ||
Combining CXCL10 gene therapy and radiotherapy improved therapeutic efficacy in cervical cancer HeLa cell xenograft tumor models | Q35870139 | ||
CXCL10 enhances radiotherapy effects in HeLa cells through cell cycle redistribution | Q35995701 | ||
Combining radiotherapy and immunotherapy: a revived partnership | Q36274581 | ||
Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria | Q36534408 | ||
Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer | Q36606214 | ||
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer | Q36985056 | ||
Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer | Q37100703 | ||
Cytokines in cancer immunotherapy | Q37148152 | ||
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment | Q37268974 | ||
Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases | Q37414046 | ||
RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. | Q37543955 | ||
CXCR3 ligands: redundant, collaborative and antagonistic functions | Q37827339 | ||
The emerging role of CXCL10 in cancer (Review). | Q38030910 | ||
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. | Q38709131 | ||
Radiotherapy and immunotherapy: a beneficial liaison? | Q39017268 | ||
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity | Q39071019 | ||
IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor | Q41228057 | ||
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. | Q41653193 | ||
Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts | Q45885057 | ||
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. | Q45931583 | ||
HPV16E7 Induced Hyperplasia Promotes CXCL9/10 Expression and Induces CXCR3+ T cell Migration to Skin | Q47255683 | ||
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. | Q55015760 | ||
Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes | Q84997348 | ||
Interferon gamma in cancer immunotherapy | Q90435682 | ||
Herpes Simplex Virus 1 MicroRNA miR-H28 Exported to Uninfected Cells in Exosomes Restricts Cell-to-Cell Virus Spread by Inducing Gamma Interferon mRNA | Q92623263 | ||
Cancer Stem Cells and Radioresistance: DNA Repair and Beyond | Q92989407 | ||
Assessing the interactions between radiotherapy and antitumour immunity | Q93053380 | ||
P304 | page(s) | 112382 | |
P577 | publication date | 2020-11-27 | |
P1433 | published in | Experimental Cell Research | Q1524289 |
P1476 | title | IFNgamma-inducible CXCL10/CXCR3 axis alters the sensitivity of HEp-2 cells to ionizing radiation |
Search more.